Expediting Discovery and Development: A Pharmaceutical Case Study
How did Mindbreeze help a pharmaceutical company speed up time to market by 50%?
The organization needed to analyze clinical trial data, drug information, and review applications faster and more consistently.
The Problems:
- Life science organizations often face challenges managing and utilizing their data effectively to make quicker and more informed decisions.
- Access to scattered data across various systems makes it practically impossible for researchers and authorities to make life-changing discoveries in a highly regulated industry.
- More than 17,000 employees (all needing critical information).
So, how did Mindbreeze help?
AI Features Used:
- Search-driven analytics for autosuggestions based on user search history, popular queries, and document keywords.
- Entity Recognition Service for automatic extraction of necessary information from large documents and datasets.
- Semantic Relations Service to identify and extract correlations of existing information and provide relevant results on a priority basis.
What happened?
With Mindbreeze, the company was able to improve and speed up time to market by 50% by freeing siloed data from legacy infrastructures, allowing them to swiftly identify and address inquiries.
How can we help your company expedite discovery and development?
For more information, you can also visit our webpage dedicated to R&D.
Latest Blogs
From Prompt Engineers to Context Engineers: The New Talent Imperative
In the race to master generative AI, "prompt engineering" became the buzzword of the year. Everyone wanted a perfect way to communicate with machines. However, as the hype fades, a more profound truth is emerging: it's not what you ask of AI, but what it knows when you ask it.
The Agentic Enterprise: When 80% of Customer Processes Run on AI
Imagine an enterprise where AI doesn’t just respond, it acts. An AI that resolves a customer ticket, updates your CRM, and notifies sales before anyone asks.